Peer Reviewed / Book Chapters / Abstracts/Posters/Scientific

Peer Reviewed Articles

  1. Pringle, J. L., Kelley, D. K., Kearney, S. M., Aldridge, A., Dowd, W., Johnjulio, W., … & Lovelace, J. (2018). Screening, Brief Intervention, and Referral to Treatment in the Emergency Department: An Examination of Health Care Utilization and Costs. Medical care56(2), 146-152.
  2. Venkat, A., Aldridge, A., Kearney, S.M., Radack, J.P., Rickard-Aasen, S., Grasso, K.M., Fawcett J.A., Pringle. J.L. (2017) Derivation of a Shortened Research Instrument for Measuring Alcohol and Other Drug (AOD) Attitudes in a Screening, Brief Intervention, and Referral to Treatment (SBIRT) Training Program. Journal of Science, Humanities, and Arts, 4(2), 1-16
  3. Pringle, J. L., Kearney, S. M., Rickard-Aasen, S., Campopiano, M. M., & Gordon, A. J. (2017). A statewide screening, brief intervention, and referral to treatment (SBIRT) curriculum for medical residents: Differential implementation strategies in heterogeneous medical residency programs. Substance Abuse38(2), 161-167.
  4. Burrell, A., Ethun, L., Fawcett, J. A., Rickard-Aasen, S., Williams, K., Kearney, S. M., & Pringle, J. L. (2017). The pharmacist’s role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution. Journal of the American Pharmacists Association57(2), S73-S77.
  5. Pringle, J., Grasso, K., & Lederer, L. (2017). Integrating the Integrated: Merging Integrated Dual Diagnosis Treatment (IDDT) with Housing First. Community Mental Health Journal, 1-7.
  6. Pringle, J. L., Seale, J. P., Shellenberger, S., Grasso, K. M., Kowalchuk, A., Laufman, L., … & Aldridge, A. (2017). Development and evaluation of two instruments for assessing screening, brief intervention, and referral to treatment (SBIRT) competency. Substance abuse, 38(1), 43-47.
  7. Pringle JL; Aldridge AP; Kearney SM; Grasso KM; Radack J; Hogue S; Manolis C. (2016) Evaluating the Impact of Sample Medication on Subsequent Patient Adherence. Journal of Managed Care & Specialty Pharmacy, 22(11) 1262-1269.
  8. Kearney SM; Aldridge AP; Castle NG; Peterson J; Pringle JL. (2016) The Association of Job Strain with Medication Adherence: Is your job affecting your compliance with a prescribed medication regimen? Journal of Occupational and Environmental Medicine, 58(7), 707-711
  9. Pringle JL; Chan C; Rucker L; Burns A; Domann D; Tice B. (2016) Perspectives: Applying Value-Based Incentive Models within Community Pharmacy Practice. American Journal of Pharmacy Benefits. January/February 2016.
  10. Pringle JL; Coley K. (2015) Improving Medication Adherence: A Framework for Community Pharmacy-Based Interventions. Integrated Pharmacy Research and Practice. Dove Medical Press.
  11. Pringle JL; Kearney S; Grasso K; Boyer A; Conklin A; Conklin M; Szymanski. (2015) User Testing and Performance Evaluation for the Electronic Quality Improvement Platform for Plans and Pharmacies (EQuIPP). Journal of the American Pharmacists Association (JAPHA).
  12. Janice L. Pringle, Annette Boyer, Mark H. Conklin, Jesse W. McCullough, and Arnie Aldridge
    The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence And Reduced Health Care Costs
    Health Aff. 2014 33: 1444-1452.
  13. Melczak M, Pringle J. (2011). “Until they know how much you care”: A qualitative analysis of an innovative practice in community pharmacy. Innovations in Pharmacy, 2,
  14. Pringle, J; Melczak, M; Aldridge, A; Snyder, M; Smith, R. (2011) Medication adherence and its relationship to the therapeutic alliance: Results from an innovative pilot study within a community pharmacy MTM practice. Innovations in Pharmacy, 2(1).
  15. McGrath SH, Snyder ME, Duenas GG, Pringle JL, Smith RB, McGivney MS. (2010) Physician perceptions of pharmacist-provided medication therapy management: Qualitative analysis. Journal of the American Pharmacists Association, 50(1), 67-71.
  16. Pringle J; Weber R; Sirio, C; Kirisci, L; Rice K. (2009) A Region-Wide Approach to Determining Patient Safety Culture. American Journal of Medical Quality, 24(5), 364-384.
  17. Holland, C; Pringle, J; Barbetti, V. (2009) Identification of Physician Barriers to the Application of Screening and Brief Intervention for Problem Alcohol and Drug Use. Alcoholism Treatment Quarterly 27 (2), 174-183.
  18. Colombi, A; Pringle, J; Welsh, G. (2008) “Not Waiting for Godot: The Evolution of Health Promotion at PPG Industries,” American Health and Drug Benefits, 1(3), 28-36.
  19. Holland CL; Pringle JL. (2008) Barriers to Identification of Problem Alcohol and Drug Use: Results of Statewide Focus Groups. Alcoholism Treatment Quarterly, 27(2), 174-183.
  20. Stewart C; Koeske G; Pringle J. (2007) Religiosity as a Predictor of Successful Post-Treatment Abstinence for African-American Clients. Journal of Social Work Practice in Addictions, Vol 7(4).
  21. Pringle JL; Emptage NP; Barbetti V.(2007) The Role of Spirituality in Alcohol Treatment Outcomes among African American Patients. Alcoholism Treatment Quarterly, 25(3).
  22. Coley KC; Pringle JL; Weber RJ, et al. (2006) Perceived Barriers in Using a Region-Wide Medication Error Reporting System. Journal of Patient Safety. 2:39-44.
  23. Pringle JL; Emptage NP; Hubbard RL. 2006) Unmet need for wrap around services in outpatient addiction treatment. The Journal of Substance Abuse Treatment 30(3): pp 183-189.
  24. Pringle JP; Edmondston LE; Holland CL et al. (2002). The Role of Wrap Around Services in Retention and Outcome in Substance Abuse Treatment: Findings from the Wrap Around Services Impact Study. Addictive Disorders and Their Treatment, 1(4): (pp 109-118).
  25. Etheridge RM; Pringle JL; Hubbard RL; Wald H; Emptage NP; Saavedra-Leberknight M. (1999) Response to R. Fiorentine, “Effective Drug Treatment: Testing the Distal Needs Hypothesis.” Journal of Substance Abuse Treatment.
  26. Etheridge RM; Pringle JL; Hubbard RL; Emptage N.P. (1999) Client Outcome in Substance Abuse Treatment. St. Francis Journal of Medicine, 5(3), 116-122.
  27. Hofkosh D; Pringle JL; Wald HP; Switala J; Hinderliter SA; Hamel SC. (1995) Early Interactions among Drug-Involved Mothers and Infants: Within Group-Differences. Archives of Pediatric and Adolescent Medicine, 149(6):665-672.
  28. Pringle JL; Scott-Johnson I. (1993) Treatment Strategies for the Crack Addicted Woman. The Counselor, 11(3):14-17.
  29. Hinderliter S; Zelenak JP. (1993) A Simple Method to Identify Alcohol and Other Drug Use in Pregnant Adults in a Prenatal Care Setting. Journal of Perinatology, 13(2):93-102.
  30. Brent DA; Kolko DJ; Wartella ME; Boylan MB; Moritz G; Baugher M; Zelenak JP. (1993) Adolescent Psychiatric Inpatients’ Risk of Suicide Attempt upon Six-Month Follow-Up. Journal of the American Academy of Child and Adolescent Psychiatry, 32(1):95-105.
  31. Brent DA; Perper JA; Allman CJ; Moritz GM; Wartella ME; Zelenak JP. (1991) The Presence and Accessibility of Firearms in the Homes of Adolescent Suicides: A Case-Control Study. Journal of the American Medical Association, 266(21):2989-2995.
  32. Brent DA; Zelenak JP; Bukstein O; Brown RV. (1991) Reliability and Validity of the Structured Interview for Personality Disorders in Adolescents. Annual Progress in Child Psychiatry and Child Development, 359-372.
  33. Brent DA; Zelenak JP; Bukstein O; Brown RV. (1990) Reliability and Validity of the Structured Interview for Personality Disorders in Adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 29(3):349-358.
  34. Brent D; Perper J; Kolko DJ; Zelenak JP. (1988) The Psychological Autopsy: Metho¬dologic Considerations for the Study of Adolescent Suicide. Journal of the American Academy of Child and Adolescent Psychiatry, 27(3):362-366.
  35. Brent D; Perper J; Goldstein CE; Kolko DJ; Allan MJ; Allman CJ; Zelenak JP. (1988) Risk Factors for Adolescent Suicide: A Comparison of Adolescent Suicide Victims with Suicidal Inpatients. Archives of General Psychiatry, 45(6):581-588.
  36. Zelenak JP; Alarie Y; Weyel DA. (1982) Assessment of the Cough Reflex Caused by Inhalation of Sodium Lauryl Sulfate and Citric Acid Aerosols. Fundamentals and Applied Toxicology, 2(4):177-180.
  37. Maronpot RR; Zelenak JP; Weaver EV; Smith NJ. (1983) Terato¬genicity Study of Ethylene Glycol in Rats. Drug and Chemical Toxicology, 6(6):579-594.
  38. Snellings, WM; Maronpot, RR; Zelenak, JP; Laffoon, CP. (1982) Teratology Study in Fischer 344 Rats Exposed to Ethylene Oxide by Inhalation. Toxicology and Applied Pharmacology, 64(3):476-481.
  39. Snellings, WM; Zelenak, JP; Weil, CS. (1982) Effects on Reproduction in Fischer 344 Rats Exposed to Ethylene Oxide by Inhalation for One Generation. Toxicology and Applied Pharmacology, 63(3):382-388.

Book Chapters

  1. Johnjulio W; Pringle J. (2010) Developing and Evaluating SMaRT: SBIRT Medical and Residency Training in Medical Residency Programs in Pennsylvania. Journal of Substance Abuse, Vol 31(3), 193 – 219.
  2. Pringle J; Weber RJ; Rice K; Kirisci L; Sirio C. (2009) Examination of How a Survey Can Spur Culture Using a Quality Improvement Approach: A Region-Wide Approach to Determining a patient Safety Culture. American Journal of Medical Quality, Vol 24(5), 374-384.
  3. Pringle JP; McLeod J. (2008) Lean Care in the Behavioral Healthcare Setting. In Fry HM and Schuldt LM (Eds.) Advanced Lean Thinking: Proven Methods to Reduce Waste and Improve Quality in Health Care (pp. 139-146). Printed in U.S.A.: Joint Commission on Accreditation of Healthcare Organizations.
  4. Wald HP; Flaherty MT; Pringle JL. (1999). Prevention in Prisons. In R.T. Ammerman, P.J. Ott, & R.E. Tarter (Eds.), Prevention and Societal Impact of Drug and Alcohol Abuse (pp. 369-381). Mahwah, NJ: Lawrence Erlbaum Associates.
  5. Pringle JP; Kostyak LR; Flaherty MT. (1999) Managed Care and Substance Abuse. In R. Ammerman, P.J. Ott, R.T. Tarter (Eds.), Prevention and Societal Impact of Drug and Alcohol Abuse (pp. 165-184). Mahwah, NJ: Lawrence Erlbaum Associates.
  6. Pringle JP; Hinderliter S; Reynolds M; Dixon L; Flaherty MT. (1994) Treatment of the Pregnant Addict. Providence, RI: Behavioral Health Resource Press, Manisses Communications Group.


  1. Association for Medical Education and Research in Substance Abuse (AMERSA). November, 2009. Bethesda, MD.
  2. Poster: Implementation Lessons Learned: Experience of the Pennsylvania Screening and Brief Intervention, and Referral to Treatment Project (PA SBIRT)